Categories: News

RaySearch receives largest order to date – wins major public tender for RayStation and RayCare in Spain

RaySearch Laboratories AB (publ) announces that the proton therapy machine vendor Ion Beam Applications S.A. (IBA), has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®* to be installed at nine proton centers in Spain. RaySearch participated in the public tender in partnership with IBA, which is the main system integrator. Total order value is EUR 17.3 million of which EUR 14.9 million is for software licenses.

In 2021, the Spanish Ministry of Health and the Amancio Ortega Foundation signed an agreement under which the Foundation donated EUR 280 million to the Ministry of Health for the purchase of 10 proton therapy units, in nine centers, to be installed across the country. The publich tender was launched in July 2022 and included three rounds to choose the companies eligible of providing proton therapy equipment to the Spanish National Health System.

The order includes both RayStation and RayCare at all centers. The combination of RayStation and RayCare, together with an IBA proton therapy machine, provides an integrated and unified solution throughout the complete workflow.

Johan Löf, founder and CEO, RaySearch, says: “We are proud to supply both RayStation and RayCare to this extensive investment in proton therapy in Spain. For RaySearch, this means a further strengthening of our leading position in treatment planning for protons as well as a significant increase of our customer base for RayCare. The fact that all centers will use both RaySearch products will bring many synergies, both in terms of implementation and clinical practice of radiation therapy in Spain.”

The order value of EUR 17.3 million (corresponding to approximately SEK 188 million) is the largest ever for RaySearch. Delivery is expected to start in 2024 and will take place over several years. Service contract is excluded in the initial order but is expected to be added at the time of delievery.

This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 03:55 pm CET on December 9, 2022.

Recent Posts

Google and News Corp’s AI Content Partnership: Unveiling a Symbiotic Relationship

In a move that could reshape the landscape of content creation and distribution, tech giant…

2 days ago

Amazon Faces Pressure to Offer Dividends Amid Peer Trends

As one of the leading e-commerce giants, Amazon.com finds itself increasingly under scrutiny to provide…

2 days ago

Nvidia’s Dominance and Its Impact on the U.S. Stock Market

Nvidia Corp (NVDA.O) has emerged as a pivotal player in the U.S. stock market, symbolizing…

2 months ago

Sarah Callery Takes the Helm as Head of Sales

Clinch, a pioneer in recruitment marketing solutions, is thrilled to announce the appointment of Sarah…

4 months ago

Bitget Introduces Spot P2P Market

Bitget, a global leader in the cryptocurrency exchange and Web3 space, has made waves with…

4 months ago

HPE Welcomes New CFO as Tech Industry Faces Turbulence: A Deep Dive into the Latest Leadership Changes

In a strategic move that reverberated across the tech industry, Hewlett Packard Enterprise (HPE) announced…

5 months ago

This website uses cookies.